Original Research
Published on 23 Feb 2023
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
in Vaccines and Molecular Therapeutics

- 2,513 views
- 3 citations
Original Research
Published on 23 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 23 Feb 2023
in Vaccines and Molecular Therapeutics

Review
Published on 22 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 22 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 21 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 21 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 20 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 17 Feb 2023
in Vaccines and Molecular Therapeutics

Review
Published on 17 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 17 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 16 Feb 2023
in Vaccines and Molecular Therapeutics

Methods
Published on 16 Feb 2023
in Vaccines and Molecular Therapeutics

Brief Research Report
Published on 16 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 14 Feb 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 14 Feb 2023
in Vaccines and Molecular Therapeutics

Systematic Review
Published on 13 Feb 2023
in Vaccines and Molecular Therapeutics
